Butobendine

This classification denotes an antiarrhythmic agent with the molecular formula C32H48N2O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) RP2J52327K, chemically known as ( )-(s,s)-ethylenebis-((methylimino)(2-ethylethylene))bis(3,4,5-trimethoxy-benzoate). but more generally known as butobendine, which bears US NIH Compound Identifier 3037620. Butobendine most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Butobendine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06025MIG. The term BUTOBENDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 35, No. 5 1981, List 21). BUTOBENDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule butobendine under HS 29221980 and SITC 51461. As of Q4 2014, BUTOBENDINE remains US FDA's Preferred Term for this commodity. Butobendine bears US NLM identifiers UMLS ID C2825628 and NCI Concept Code C81433. SMILES: O(C(NC)C(CCC(C(OC(=O)C1CC(OC)C(OC)C(OC)C1)NC)CC)CC)C(=O)C1CC(OC)C(OC)C(OC)C1.